Opioid Addiction

An online-based mindfulness treatment program significantly reduced opioid craving among participants with opioid use disorder results from a randomized clinical trial published in JAMA Network Open showed.

The volume of those who received medications for opioid use disorder at federally qualified health centers more than doubled over a recent 6-year span, results from a cross-sectional study showed.

Individuals receiving methadone for opioid use disorder had a lower risk for discontinuing treatment compared with the combination of buprenorphine and naloxone, study results published in JAMA showed.

BOSTON — There is a reduction in syringe sharing when methadone providers are spread out near areas with the greatest density of people who inject drugs, according to research presented at The Liver Meeting.

For patients with chronic pain, the right treatment could help prevent suicide, according to Kathleen M. Farrell, DO.

The risk for theoretical opioid addiction affected some patients’ choice of pain medications after Mohs micrographic surgery, according to a study.

Popular myths continue to influence the way physicians and patients alike think about and engage with chronic pain and the use of opioids, according to a speaker at the 2023 Biologic Therapies Summit.

From 2016 to 2022, initiation of buprenorphine for opioid use disorder increased, then plateaued prior to the COVID-19 pandemic, with a median monthly retention rate of about 20%, according to a research letter published in JAMA.

People with opioid use disorder who also had fibromyalgia were more likely to have pain-related exacerbation of their addiction compared with people who had chronic pain without fibromyalgia, findings published in Pain showed.

Medicare beneficiaries using telehealth services for opioid use disorder during the COVID-19 pandemic had a 33% lower risk for fatal drug overdose compared with beneficiaries receiving no treatment, findings in JAMA Psychiatry showed.